Perigon Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,358
Closed -$2.38M 856
2023
Q4
$2.38M Sell
18,358
-61
-0.3% -$8.41K 0.08% 210
2023
Q3
$3M Sell
18,419
-48
-0.3% -$8.44K 0.12% 164
2023
Q2
$3.39M Buy
18,467
+1,490
+9% +$215K 0.13% 151
2023
Q1
$2.26M Buy
16,977
+2,533
+18% +$298K 0.13% 167
2022
Q4
$1.15M Buy
14,444
+5,471
+61% +$385K 0.07% 247
2022
Q3
$543K Buy
8,973
+5,331
+146% +$344K 0.05% 316
2022
Q2
$200K Buy
+3,642
New +$211K 0.02% 541

Other funds holding ACLS

Perigon Wealth Management's ACLS Position: Q1 2024 in Review

Perigon Wealth Management sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 18,358 shares — an estimated $2.38M sold.

Perigon Wealth Management first reported a position in ACLS in Q2 2022 and held it in 7 quarters. The position peaked at $3.39M in Q2 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Perigon Wealth Management reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • Perigon Wealth Management sold 18,358 Axcelis shares in Q1 2024, an estimated $2.38M.
  • Perigon Wealth Management first reported a position in Axcelis in Q2 2022 and held it in 7 quarters.
  • Perigon Wealth Management's Axcelis position peaked at $3.39M in Q2 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Perigon Wealth Management's 13F filing for Q1 2024, filed 29 Apr 2024.